Wall Street PR

Shareholder Briefing: BlackBerry Ltd (NASDAQ:BBRY), American Realty Capital Properties Inc (NASDAQ:ARCP), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN)

Boston, MA 03/03/2014 (wallstreetpr) – BlackBerry Ltd (NASDAQ:BBRY) was last seen going down almost 5 percent to $10 in the last trading session. That drop in stock price can cause concern among some investors until they realize that the stock that was once going to the dogs is up 35 percent year to date. BBRY which is regarded as the pioneer of smartphone has lost a lot of ground to Apple Inc (NASDAQ:AAPL) and Samsung. However, since the company installed a new leadership and brought in turnaround expert John Chen, it can be seen bouncing from the deathbed. The company is turning its greater focus to enterprise business and it has also passed on the phone manufacturing mandate to Foxconn Technology which effectively means that inventory writedown will no longer be the concern of the Ontario, Waterloo-based company. Thus, analysts concur with management of BlackBerry Ltd (NASDAQ:BBRY) that best times are still ahead for the company and its investors.

American Realty Capital Properties Inc (NASDAQ:ARCP) was part of bad news on Nasdaq composite in the last trading session. The stock took a turn to the south by 0.41 percent to $14.69. That downfall followed two important reports from the company. First ARCP reported its fourth quarter 2013 earnings that showed it realized 25 cents profit per share, exceeding 23 cents that analysts had modeled for the quarter. Revenue in the quarter was also encouraging at $94.10 million, ahead of $84.30 million that analyst estimated. The second big report around American Realty Capital Properties Inc (NASDAQ:ARCP) was that it announced the appointment of Richard A. Silfen as its Executive Vice President and General Counsel.

Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) traded flat in the last session, thus ended the day at $1.35 which was the closing market in the previous session. Although the stock didn’t move an inch to the final bell, its intraday activity saw it touching high and low in the ranks of $$1.42 and $1.31 respectively. The $63.07 million capped company boasts 52-week high of $1.85 and as can be clearly seen, its current stock price is not far removed from the 12 months high point.